Autologous Versus Synthetic Versus Biological Sling for Trans-obturator Correction of Urinary Stress Incontinence

Sponsor
University Magna Graecia (Other)
Overall Status
Unknown status
CT.gov ID
NCT00744198
Collaborator
(none)
8
1
3

Study Details

Study Description

Brief Summary

The treatment of urinary stress incontinence with trans-obturator approach, know as transobturatory tape (TOT), is a largely used sling-adopting procedures. The efficacy and safety of this minimally invasive surgery have been demonstrated, also in comparison with similar procedures, i.e transvaginal tape (TVT).

To date the results of TOT in terms of efficacy and safety described in literature mainly refer to procedure in which synthetic materials are used, whereas few data regarding the use of biological materials are available. Moreover, despite the well known benefits of the available synthetic and eterologue kit, their use may be limited by the high cost of these materials. At this proposal it can be suggested as alternative option the possibility to perform the procedure using an autologous tissue, i.e. rectus fascia, and reusable introductory needles. Based on these considerations the aim of this trial will be to compare autologous, synthetic and biological mesh for TOT in women with urinary stress incontinence.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Autologous transobturator tape procedure
  • Procedure: Synthetic transobturator tape procedure
  • Procedure: Biological transobturator tape procedure
Phase 4

Detailed Description

Women with genuine stress urinary incontinence will be enrolled and randomized in three groups (arm 1, arm 2, arm 3). All patients will be treated with a transobturatory approach, in patients of arm 1 will be used an autologous tissue and reusable introductory needles, in patients of arm 2 will be used a synthetic kit whereas in arm 3 will be a biological kit .

All eligible patients will undergo baseline assessment consisting of anthropometric, clinical, hormonal, urodynamic, and ultrasonographic evaluations. During the study, the surgical outcomes, the clinical subjective and objective efficacy data, and the adverse experiences will be evaluated in each patient.

Data will be analyzed using the intention-to-treat principle and a P value of 0.05 or less will be considered significant.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
8 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Comparison in Terms of Efficacy and Safety Among Three Different Materials for Trans-obturator Correction of Urinary Stress Incontinence: Autologous, Synthetic and Biological Sling
Study Start Date :
Aug 1, 2012
Anticipated Primary Completion Date :
Aug 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1

Autologous sling

Procedure: Autologous transobturator tape procedure
A strip of rectus fascia is harvested. Small incision sites in the vagina and in the femoral/pelvic fold. Bilateral transobturator insertion of the autologous strip by means of reusable needles

Active Comparator: 2

Synthetic sling

Procedure: Synthetic transobturator tape procedure
Small incision sites in the vagina and in the femoral/pelvic fold. Bilateral transobturator insertion of synthetic mesh by means of mono-use needles.

Active Comparator: 3

Biological sling

Procedure: Biological transobturator tape procedure
Small incision sites in the vagina and in the femoral/pelvic fold. Bilateral transobturator insertion of biological mesh by means of mono-use needle

Outcome Measures

Primary Outcome Measures

  1. Cure rate [12 months]

Secondary Outcome Measures

  1. Intra-operative complication rate [one day]

  2. Postoperative complications rate [12 months]

  3. Failure rate [12 months]

  4. Recurrence rate [12 months]

  5. Quality of life [12 months]

  6. Sexual function [12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Genuine stress urinary incontinence by self report, examination and test

  • Urethral hypermobility

  • Eligible for all three surgical procedures

  • Ambulatory

Exclusion Criteria:
  • Pregnancy

  • <12 months post-partum

  • Systemic disease and/or drugs known to affect bladder function

  • Current chemotherapy or radiation therapy

  • Urethral diverticulum, augmentation cytoplasty, or artificial sphincter

  • Recent pelvic surgery

  • Severe genuine stress incontinence (loss of urine with minimal physical activity) with associated prolapse equal to or more than second degree

  • Previous pelvic or anti-incontinence surgery

  • History of severe abdominopelvic infections

  • Known extensive abdominopelvic adhesions

  • Detrusor instability and/or intrinsic sphincter dysfunction

  • Other gynaecologic pathologies (eg, fibroids, ovarian cysts)

  • BMI >30

Contacts and Locations

Locations

Site City State Country Postal Code
1 "Pugliese" Hospital Catanzaro Italy 88100

Sponsors and Collaborators

  • University Magna Graecia

Investigators

  • Principal Investigator: Stefano Palomba, MD, Chair of Obstetrics and Gynecology, University "Magna Graecia" of Catanzaro
  • Study Chair: Fulvio Zullo, MD, Chair of Obstetrics and Gynecology, University "Magna Graecia" of Catanzaro

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Stefano Palomba, Associate Professor, University Magna Graecia
ClinicalTrials.gov Identifier:
NCT00744198
Other Study ID Numbers:
  • 02/2008
First Posted:
Aug 29, 2008
Last Update Posted:
Apr 8, 2013
Last Verified:
Apr 1, 2013
Keywords provided by Stefano Palomba, Associate Professor, University Magna Graecia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 8, 2013